Article Details

Pfizer's Novel COVID-19 Oral Treatment Demonstrates In Vitro Efficacy Against Omicron Variant

Retrieved on: 2022-01-20 17:21:38

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's Novel COVID-19 Oral Treatment Demonstrates In Vitro Efficacy Against Omicron Variant. View article details on HISWAI: https://www.hospimedica.com/covid-19/articles/294791289/pfizers-novel-covid-19-oral-treatment-demonstrates-in-vitro-efficacy-against-omicron-variant.html

Excerpt

These findings provide confirmation to Pfizer's findings that nirmatrelvir is the only orally administrable, authorized/approved compound which, to ...

Article found on: www.hospimedica.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up